Additionally, a ratio combining Ki-67 with other immunohistochemical markers—ER, PR, and p53—was found to effectively predict lymph node metastasis in early-stage cases, with an AUC as high as 0.876 [48]. Here, MKI67 is linked to metastatic malignant neoplasm in the lymph nodes.